http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111543389-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111543389-B |
| titleOfInvention | A method for constructing a rat model of liver fibrosis |
| abstract | The invention relates to the field of biotechnology, in particular to a method for constructing a rat model of liver fibrosis, which comprises step 1, selecting 5-week-old BALB/c mice to construct a model; step 2, adopting a volume percentage concentration of 50% The carbon tetrachloride solution was administered by gavage to the mice; step 3, intragastric administration for 5 weeks, twice a week, to obtain liver fibrosis mice. The present invention screens and predicts effective drugs for preventing and treating liver fibrosis by constructing an experimental animal model similar to the etiology, course and pathology of human liver fibrosis, proving the medicinal uses and pharmacological effects of the drugs in preventing and treating liver fibrosis, and evaluating the effect of related drugs on the prevention and treatment of liver fibrosis. The efficacy of the disease. |
| priorityDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.